GOLDENWELL BIOTECH, INC. (GWLL) Gross profit 2019–2025
GOLDENWELL BIOTECH, INC. (GWLL) annual gross profit history from SEC filings — each fiscal year as reported.
$12FY2025 · since FY2019: $0 → $12
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $12 | -81.3% |
| FY2024 | $64 | -90.4% |
| FY2023 | $666 | -97.4% |
| FY2022 | $25,186 | +200.3% |
| FY2021 | $8,388 | — |
| FY2020 | $0 | — |
| FY2019 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More GWLL financial trends
GWLL RevenueGWLL Net incomeGWLL Net marginGWLL Gross marginGWLL Operating incomeGWLL Operating marginGWLL Operating cash flowGWLL Free cash flowGWLL Capital expendituresGWLL Return on equityGWLL Stock buybacksGWLL Dividends paidGWLL Total assetsGWLL Total liabilitiesGWLL Shareholders’ equityGWLL overview →